Chronic EBV Reactivation Protocol
Supportive protocol for suspected Epstein-Barr virus reactivation using immune support, sleep, stress care and, when a clinician decides it fits, antiviral medication.
35/100
Various integrative immunologists
6 to 12 months; some people need longer support with their clinician
21 phases
3 conditions
Protocol Overview
Supportive protocol for suspected Epstein-Barr virus reactivation using immune support, sleep, stress care and, when a clinician decides it fits, antiviral medication. Evidence that this pattern causes chronic fatigue is limited.
Used For
Key Resources
Safety Profile
EBV infects about 90% of adults and causes mononucleosis. It usually stays dormant and can reactivate with stress, immune suppression or illness. Whether reactivation drives long-term fatigue is debated, and test cutoffs for chronic reactivation are not standardized. EBV is strongly linked to later multiple sclerosis (a 2022 study in Science found a 32-fold higher risk after infection) and is studied in lupus and other autoimmune diseases. Antivirals such as valacyclovir are used off-label by some clinicians, with limited evidence. L-lysine, monolaurin, olive leaf, lemon balm and cat's claw have lab or small clinical studies. Sleep and stress management matter: stress hormones weaken the immune cells that keep the virus in check. Low-dose naltrexone is being explored for chronic fatigue. The aim is to support immune control, address gut health and nutrient status, and rule out other causes of fatigue with a clinician.
Find a Practitioner
Gabriel can find and book a practitioner who works with this approach.
Book with GabrielAbout Evidence Score
The Evidence Score (0 to 100) rates the strength of evidence from studies in people for the uses listed: higher means stronger, more consistent research. It does not measure safety. It is not medical advice.
For education, not medical advice. Talk with a licensed clinician before you start, and never stop or change a prescribed medication without your prescriber.